These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16799155)

  • 61. The noncatalytic amino terminus of mitogen-activated protein kinase phosphatase 1 directs nuclear targeting and serum response element transcriptional regulation.
    Wu JJ; Zhang L; Bennett AM
    Mol Cell Biol; 2005 Jun; 25(11):4792-803. PubMed ID: 15899879
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens.
    Chen JR; Plotkin LI; Aguirre JI; Han L; Jilka RL; Kousteni S; Bellido T; Manolagas SC
    J Biol Chem; 2005 Feb; 280(6):4632-8. PubMed ID: 15557324
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multiple Ets factors and interferon regulatory factor-4 modulate CD68 expression in a cell type-specific manner.
    O'Reilly D; Quinn CM; El-Shanawany T; Gordon S; Greaves DR
    J Biol Chem; 2003 Jun; 278(24):21909-19. PubMed ID: 12676954
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Involvement of the activation loop of ERK in the detachment from cytosolic anchoring.
    Wolf I; Rubinfeld H; Yoon S; Marmor G; Hanoch T; Seger R
    J Biol Chem; 2001 Jul; 276(27):24490-7. PubMed ID: 11328824
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2.
    Cunnick JM; Mei L; Doupnik CA; Wu J
    J Biol Chem; 2001 Jun; 276(26):24380-7. PubMed ID: 11323411
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sp1 is a co-activator with Ets-1, and Net is an important repressor of the transcription of CTP:phosphocholine cytidylyltransferase alpha.
    Sugimoto H; Okamura K; Sugimoto S; Satou M; Hattori T; Vance DE; Izumi T
    J Biol Chem; 2005 Dec; 280(49):40857-66. PubMed ID: 16157598
    [TBL] [Abstract][Full Text] [Related]  

  • 67. p73 supports cellular growth through c-Jun-dependent AP-1 transactivation.
    Vikhanskaya F; Toh WH; Dulloo I; Wu Q; Boominathan L; Ng HH; Vousden KH; Sabapathy K
    Nat Cell Biol; 2007 Jun; 9(6):698-705. PubMed ID: 17496887
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
    Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
    Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.
    Soudant N; Albagli O; Dhordain P; Flourens A; Stéhelin D; Leprince D
    Nucleic Acids Res; 1994 Sep; 22(19):3871-9. PubMed ID: 7937106
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection.
    Baines CP; Zhang J; Wang GW; Zheng YT; Xiu JX; Cardwell EM; Bolli R; Ping P
    Circ Res; 2002 Mar; 90(4):390-7. PubMed ID: 11884367
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An affinity for motifs.
    Doerr A
    Nat Methods; 2011 Aug; 8(8):620. PubMed ID: 21916037
    [No Abstract]   [Full Text] [Related]  

  • 72. Hydrogen peroxide-dependent oxidation of ERK2 within its D-recruitment site alters its substrate selection.
    Postiglione AE; Adams LL; Ekhator ES; Odelade AE; Patwardhan S; Chaudhari M; Pardue AS; Kumari A; LeFever WA; Tornow OP; Kaoud TS; Neiswinger J; Jeong JS; Parsonage D; Nelson KJ; Kc DB; Furdui CM; Zhu H; Wommack AJ; Dalby KN; Dong M; Poole LB; Keyes JD; Newman RH
    iScience; 2023 Oct; 26(10):107817. PubMed ID: 37744034
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development of Erf-Mediated Craniosynostosis and Pharmacological Amelioration.
    Vogiatzi A; Keklikoglou K; Makris K; Argyrou DS; Zacharopoulos A; Sotiropoulou V; Parthenios N; Gkikas A; Kokkori M; Richardson MSW; Fenwick AL; Archontidi S; Arvanitidis C; Robertson J; Parthenios J; Zacharakis G; Twigg SRF; Wilkie AOM; Mavrothalassitis G
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175668
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structural Insight into the DNA Binding Function of Transcription Factor ERF.
    Hou C; McCown C; Ivanov DN; Tsodikov OV
    Biochemistry; 2020 Nov; ():. PubMed ID: 33175491
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetic Causes of Craniosynostosis: An Update.
    Goos JAC; Mathijssen IMJ
    Mol Syndromol; 2019 Feb; 10(1-2):6-23. PubMed ID: 30976276
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells.
    Selvaraj N; Kedage V; Hollenhorst PC
    Cell Commun Signal; 2015 Feb; 13():12. PubMed ID: 25885538
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Small-molecule inhibitors of ERK-mediated immediate early gene expression and proliferation of melanoma cells expressing mutated BRaf.
    Samadani R; Zhang J; Brophy A; Oashi T; Priyakumar UD; Raman EP; St John FJ; Jung KY; Fletcher S; Pozharski E; MacKerell AD; Shapiro P
    Biochem J; 2015 May; 467(3):425-38. PubMed ID: 25695333
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis.
    Twigg SR; Vorgia E; McGowan SJ; Peraki I; Fenwick AL; Sharma VP; Allegra M; Zaragkoulias A; Sadighi Akha E; Knight SJ; Lord H; Lester T; Izatt L; Lampe AK; Mohammed SN; Stewart FJ; Verloes A; Wilson LC; Healy C; Sharpe PT; Hammond P; Hughes J; Taylor S; Johnson D; Wall SA; Mavrothalassitis G; Wilkie AO
    Nat Genet; 2013 Mar; 45(3):308-13. PubMed ID: 23354439
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cells.
    Allegra M; Zaragkoulias A; Vorgia E; Ioannou M; Litos G; Beug H; Mavrothalassitis G
    Mol Biol Cell; 2012 Oct; 23(19):3873-81. PubMed ID: 22875994
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.
    Burkhard KA; Chen F; Shapiro P
    J Biol Chem; 2011 Jan; 286(4):2477-85. PubMed ID: 21098038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.